Ledger.Open graph →
SEC Form D · filed February 3, 2020

Inflammatix, Inc

Offering
$32.1M
Sold
$32.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BURLINGAME, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Kenneth Bahk · BURLINGAME, CADirectorSteven Tablak · BURLINGAME, CADirectorAusten Helfrich · Salt Lake City, UTDirectorSC Management LLC Management SC Management SC Management LLC · New York, NYDirectorJonathan Romanowsky · BURLINGAME, CAExecTimothy Sweeney · BURLINGAME, CAExec · DirectorArnold Kozys · Markham, ILDirectorJingjing Zhang · Markham, ILDirectorJonathan Romanowsky · BURLINGAME, CAExecAcies Management LLC · Markham, ILDirectorNed Mahic · Markham, ILDirectorDavid Persing · BURLINGAME, CADirectorMichael Rubin · BURLINGAME, CADirectorKyle White · Salt Lake City, UTDirectorSC Management LLC Management SC Management SC SC Management LLC · New York, NYExec · DirectorThejas Nalval · Hoboken, NJExec · DirectorJason M. Stein · Brooklyn, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗